Mutation in the platelet-derived growth factor receptor alpha inhibits adeno-associated virus type 5 transduction.

Autor: Pilz IH; Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA. ingo.hinrich.pilz@uniklinik-freiburg.de, Di Pasquale G, Rzadzinska A, Leppla SH, Chiorini JA
Jazyk: angličtina
Zdroj: Virology [Virology] 2012 Jun 20; Vol. 428 (1), pp. 58-63. Date of Electronic Publication: 2012 Apr 20.
DOI: 10.1016/j.virol.2012.03.004
Abstrakt: Due to its non-pathogenic lifecycle, little is known about the cellular determinants of infection by adeno-associated virus (AAV). To identify these critical cellular factors, we took advantage of the gene transfer abilities of AAV in combination with a forward genetic selection to identify proteins critical for transduction by this virus. AAV serotype 5 (AAV5) vectors encoding the furin gene were used to transduce furin-deficient cells followed by selection with furin-dependent toxins. A population of cells specifically resistant to AAV5 transduction was identified and sequence analysis suggested all had a single amino acid mutation in the leader sequence of the platelet-derived growth factor receptor alpha (PDGFRα) gene. Characterization of this mutation suggested it inhibited PDGFRα trafficking resulting in limited expression on the plasma membrane. Mutagenesis and transfection experiments confirmed the effect of this mutation on PDGFRα trafficking, and the AAV5 resistant phenotype could be rescued by transfection with wild type PDGFRα.
(Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: